Mumbai airport begins vaccine transportation; 2,400 vials airlifted to Goa

People carry a batch of Covid-19 vaccine in India

COVID-19 vaccine transportation from Mumbai's Chhatrapati Shivaji Maharaj International Airport (CSMIA) commenced on Wednesday with budget carrier GoAir airlifting 2,400 vials of Covishield to Goa.

The Wadia Group-owned no-frills airline has scheduled flights carrying vaccines to Lucknow, Cochin and Chandigarh as well, besides Goa, during the day, a GoAir spokesperson told PTI.

GoAir's first flight carrying 2,400 vials (24,000 doses) of Covishield vaccine took off at 5.20 am and reached Goa at 6.30 am, the spokesperson said.

A massive pan-India inoculation drive against COVID-19 was set in process on Tuesday with more than 56 lakh doses of the Covishield vaccine leaving Pune for 13 cities across the country, four days before the vaccinations are scheduled to begin on January 16.

Covishield is developed by Oxford University and British-Swedish company AstraZeneca and manufactured by Pune-based pharma firm Serum Institute of India (SII).

GoAir said it will airlift a total of 69,600 vials of the vaccine.

Mumbai airport, which is the "largest pharma hub", is looking to cater to at least 16 destinations in the roll-out of the COVID-19 vaccines, the private airport operator had said in a statement to PTI on Tuesday.


(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel